Related Experiment Video
Updated: Jul 25, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
Statistical models for longitudinal biomarkers of disease onset
1School of Operations Research and Industrial Engineering and Department of Statistical Science, Cornell University, Ithaca, NY 14853-3801, USA. slate@orie.cornell.edu
This study introduces two novel statistical models for analyzing serial biomarker data to detect disease onset. These methods, applied to prostate-specific antigen (PSA) data, offer improved monitoring and screening for prostate cancer.
Area of Science:
- Biostatistics
- Medical Informatics
- Epidemiology
Background:
- Serial biomarker data are crucial for disease screening and monitoring but are often subject to measurement error.
- Accurate detection of disease onset is vital for timely intervention and improved patient outcomes.
- Existing methods may not fully account for the complexities of longitudinal biomarker data and error structures.
Purpose of the Study:
- To evaluate two recently proposed statistical models for analyzing serial biomarker data to detect disease onset.
- To develop dynamic indices reflecting the strength of evidence for disease onset over time.
- To compare the performance of these novel methods against standard diagnostic criteria using prostate-specific antigen (PSA) data.
Main Methods:
- A fully Bayesian hierarchical structure for a mixed-effects segmented regression model was employed, utilizing Gibbs sampling for posterior estimation of the changepoint (onset time) distribution.
- A hidden changepoint model was implemented, estimating the onset time distribution via maximum likelihood using the Expectation-Maximization (EM) algorithm.
- Both models generate a dynamic index to quantify the evidence of disease onset by the current time for individual subjects.
Main Results:
- The Bayesian and hidden changepoint models provide dynamic indices for assessing disease onset.
- Application to large prostate-specific antigen (PSA) datasets demonstrated the utility of these models for prostate cancer monitoring.
- Receiver Operating Characteristic (ROC) curves, adapted for longitudinal data, were used to compare index-based rules with standard diagnostic criteria.
Conclusions:
- The proposed Bayesian and hidden changepoint models offer robust frameworks for analyzing serial biomarkers and detecting disease onset.
- These dynamic indices provide a quantitative measure of evidence for disease onset, aiding in early detection and monitoring.
- The methods show promise for improving screening and diagnostic accuracy in longitudinal studies, as evidenced by PSA data analysis.
More Related Videos
Related Concept Videos
Longitudinal Research
Mechanistic Models: Compartment Models in Individual and Population Analysis
Steps in Outbreak Investigation
Longitudinal Studies
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time until a...
Assumptions of Survival Analysis

